Cytochrome P450 CYP1B1 activity in renal cell carcinoma-Reference-Cited by-同舟云学术

Cytochrome P450 CYP1B1 activity in renal cell carcinoma

Published:2004-07-27 Issue:5 Volume:91 Page:966-971
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

McFadyen M C E,Melvin W T,Murray G I

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602053.pdf

Reference43 articles.

1. Bournique B, Lemarie A (2002) Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme. Drug Metab Dispos 30: 1149–1152

2. Bradford M (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 74: 248–254

3. Burke MD, Mayer RT (1974) Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab Dispos 2: 583–588

4. Chang TK, Lee WB, Ko HH (2000) Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can J Physiol Pharm 78: 874–881

5. Chang TKH, Chen J, Pillay V, Ho J-Y, Bandiera SM (2003) Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver. Toxicol Sci 71: 11–19

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mécanismes de résistance aux traitements des cancers;Bulletin du Cancer;2024-01

2. Design, Synthesis, and Evaluation of 18F-Labeling CYP1B1 PET Tracer Based on 2-Phenylquinazolin;Bioorganic & Medicinal Chemistry Letters;2023-11

3. 16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism;Molecular and Cellular Biochemistry;2023-07-12

4. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect;Clinical Pharmacokinetics;2022-09-30

5. Repurposing antifungal drugs for cancer therapy;Journal of Advanced Research;2022-09